FutureFemHealth

FutureFemHealth

Home
Work with us / Advertise
CensHERship
Archive
About

Sitemap - 2023 - FutureFemHealth

Boost for endometriosis with $13.5m Heranova Lifesciences debut

Issue 33: €2.3m for Yoni period care | 2023 look-back | At-home fertility test from Arva Health | CE mark for ASPIVIX

Issue 32: $2m for MIM Fertility | Two acquisitions in period care | Postpartum long-term health issues

Issue 31: 300% rise in FemTech funding | Mosie Baby first | Censorship online | $425m acquisition for Bonafide

Mosie Baby becomes first company to secure FDA clearance for at-home intravaginal insemination

Issue 30: Béa Fertility eyes US expansion | New Clue & ŌURA partnership | How to get more money into women's health?

What's the role of clinical safety in FemTech?

Issue 29: Govt scraps period pant tax | $6m for Inito fertility | new NICE guidance on menopause

Issue 28: $14m for Needed | The White House goes for women's health | period pant silver risk?

Issue 27: $10m for Allara hormonal chronic care | More FemTech funding for men | Flo Health's partner feature | Fertility add-ons get rated

Issue 26: $17m for AOA Dx ovarian test | GenM partners Sainsbury's | Fertility boost from CHLOE AI tool | Daye's diagnostic tampon trial

Issue 25: $20m for Pollin Fertility | Talking heart health | Menopause AI | Clue co-CEO departs

Issue 24: $32m new FemHealth VC fund | viral TikToks for period cup Sunny | Is menopause a disability?

Issue 23: $44m for new ultrasound tech | Ozempic takes on fertility? | The Lowdown expands

Issue 22: $1m for Mosie Baby | FDA clears Natural Cycles & Apple Watch pairing | Hot flushes predictor from Embr Labs

Issue 21: Data privacy crackdown on FemTech apps | $2.2 for Pumpspotting | AIVF boosts IVF success

Issue 20: Clue enters perimenopause | $4.24m for bladder care company Jude | False claims about fertility tests

Issue 19: Future of the womb transplant, $3.1m for Nevia Bio, beta launch for Embody's private period tracker

Issue 18: FIFA kicks off women's health project | $10.1m for Visana Health clinic | Hanx launches new supplement range

Issue 17: That period product study, HeyJane expands, the fertility supplements that contain lead, spiral tampon gets FDA-approved

Issue 16: Will FemTech do a 'Monzo', outsized returns for menopause investors, the first pill for postpartum depression

Issue 15: FemTech Barbie | £2.5m for the at-home Béa fertility kit | healthtech female founders on the rise

Issue 14: 🌟 The boom in menopause telehealth; four global growth opportunities for FemTech; unlocking the potential of menstrual blood

Issue 13: Ad censorship pressure on Meta | attitudes to female founders profoundly different to men | Daye's world-first period pain clinic

Issue 12: Elvie celebrates 10 years | jab-free IVF coming? | $1m boost for at-home pregnancy wearable

Issue 11: Fertility support in the workplace gets a boost with £5m for Fertifa

Issue 10: ☀️ AI in fertility, from pelvic pain to entrepreneur, Govt money for healthtech & more

Issue 9:👩🏽‍💻 $1,600 hormone summit, wearables plug research gap, taboo tech & more

Issue 8: Davina McCall's Pill Revolution; the new British Standard for workplaces; and FemTech news

Issue 7: 🌟 Stories smash stigma: Naga Munchetty talks about adenomyosis

Issue 6: 👋🏼 Data breach fine for Premom, shocking NHS fertility report, Maven on TikTok

Issue 5: Fezolinetant approved, funding gap visualisation, the rise of fertility psychics (9-16 May 2023)

Issue 4: We still have a problem - 30 years since women were allowed in clinical trials

Issue 3: Data privacy, transparency and trust in FemTech

Issue 2: The state of funding for FemTech (where's all the money?)

Issue 1: This is just the start for FemTech and women's health innovation

© 2025 FutureFemHealth
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture